Developing drugs targeting the PI3K/AKT signalling

Date 10 October 2016
Event ESMO 2016 Congress
Session Transforming academia-industry partnerships to expedite clinical development of innovative anti-cancer agents
Topics Drug Development
Presenter Li Yan
Authors L. Yan
  • GSK Oncology, Collegeville/US